drugset / Trial / NCT00607230

Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics

NCT00607230 ↗

Phase 1 Completed 25 enrolled Massachusetts General Hospital
RandomizedSingle-groupQuadruple-blindTreatment

Summary

Type 1 diabetes is caused by an autoimmune destruction of the insulin producing cells of the pancreas. The investigators have discovered the specific autoimmune cells responsible for destroying the insulin-producing cells in an animal model of type 1 diabetes, and the means of destroying those cells.

Timeline

Start
2007-11
Primary completion
2010-12
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject BCG Vaccine — —